Enrique Zudaire

Company: Caribou Biosciences

Job title: Senior VP of Translational Sciences & Therapeutic Discovery

Seminars:

Clinical Readouts From CB-010, an Allogeneic Genome-Edited Anti-CD19 CAR-T Cell Therapy 11:45 am

Utilizing chRDNA genome-editing technology to engineer more precise genome edits Developing armoring strategies that improve antitumor response in allogeneic CAR-T cell therapies Reporting safety and efficacy dose escalation data from the ongoing CB-010 ANTLER Phase 1 trialRead more

day: Day 2 Track B AM